EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today certain additional information about its license agreement with Conor Medsystems, Inc. (Nasdaq: CONR).
